Medical Technology Association of India (MTaI) also stressed on ease of doing business stating that profits are coming down in the segment with government enforcing price caps on medical devices using the same formula as being done in case of drugs.
The body also asked for applying differential pricing for drug-eluting stents by classifying them on the basis of technology used.
"The government needs to recognise that medical technology sector is capital intensive with a long gestation period requiring continual infusion of technology and accordingly take a nuanced approach in its policy-making mechanisms," MTaI Director General Pavan Choudary told reporters here.
"First, we need globally harmonised regulatory policies providing safe and effective products for patients in India and abroad. Beyond products, policies around investments, infrastructure, research and development add to the appeal of manufacturing in India," he said.
Secondly, companies need to gain financial viability for making in India through various tax waivers or incentives, he added.
"And thirdly, we need more impetus on healthcare infrastructure," Khanna said.
MTaI member Probir Das said that to start with, regulations specific to medical devices must be laid out, which recognise the difference between medical devices and drugs.
In February this year, government capped the price of coronary stents. It is also said to be working to bring various other medical devices under price control.
It is also pushing local manufacturing to bring down the cost of medical devices.
In February, the government had notified new rules to remove regulatory bottlenecks and ensure availability of medical devices for patients.
The government plans to bring in a new law to promote and regulate medical devices industry as well as rationalise duty structure on imported equipment.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
